A biopharma used BIOVIA Discoverant to cut non-value-added data work by 75%.

Compiling and contextualizing data and slow risk assessment held back cost reduction. The company used BIOVIA Discoverant as its manufacturing analytics engine. The page states a 75% decrease in non-value-added activities, supporting the Golden Batch concept with better yield and purity at lower cost.

Dassault Systèmes is a software group whose BIOVIA brand serves pharma with lab, data and manufacturing analytics tools such as Discoverant and Pipeline Pilot

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.